We previously demonstrated a significant increase in CXCR6 expression in platelets, neutrophil-, monocyte- and T-cell-platelet aggregates, as well as platelet-free monocytes and T-cells, in patients with COPD when compared with volunteers without COPD (11). Here, CXCR6 is linked to chronic obstructive pulmonary disease.